Stocktoria
LifeStance Health Group, Inc. LFST
Nasdaq · stock · Services-Health Services · website · IPO 2021-06-10
LifeStance Health Group, Inc. financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.1B | $859.5M | $667.5M |
| SG&A expense | $382.2M | $363.1M | $410.8M | $378.0M | $433.7M |
| Operating income | $24.1M | -$31.6M | -$189.1M | -$210.2M | -$286.4M |
| Interest expense | $11.7M | $26.5M | $21.2M | $19.9M | $38.9M |
| Income tax | $2.7M | -$170,000 | -$20.3M | -$17.2M | -$25.9M |
| Net income | $9.7M | -$57.4M | -$186.3M | -$215.6M | -$307.2M |
| Operating cash flow | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M |
| Free cash flow | $110.0M | $85.7M | -$57.4M | -$26.5M | -$85.1M |
| Cash & equivalents | $248.6M | $154.6M | $78.8M | $108.6M | $148.0M |
| Total assets | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B |
| Total liabilities | $682.9M | $672.0M | $681.0M | $655.1M | $382.1M |
| Shareholders' equity | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B |
Growth · year-over-year · Revenue CAGR 20.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | +13.9% | +18.5% | +22.8% | +28.8% | — |
| Free cash flow growth | +28.4% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.